Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Endogenous brain cannabinoid is neuroprotective in mice with traumatic brain injury

Oct. 11, 2001

Companies collaborate on the development of novel Alzheimer's vaccine

Oct. 11, 2001

Daiichi presents chemistry and pharmacology for diaminobutane AMPA receptor antagonists

Oct. 10, 2001

PLG microsphere formulation of human beta-amyloid(1-42) induces significant serum antibody response

Oct. 10, 2001

Copaxone reduces the percentage of permanent "black holes" in MS

Oct. 10, 2001

Potential treatments for Alzheimer's disease recently presented by DuPont

Oct. 9, 2001

Studies in transgenic mice demonstrate positive effects of AMPAkines in ADHD

Oct. 9, 2001

FAUC-179 discovered at German university as potent and selective D4 partial agonist

Oct. 9, 2001

CREB-based drugs enter animal testing for improving memory

Oct. 9, 2001

Synthesis and use of nAChR receptor ligands described by AstraZeneca

Oct. 8, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...